Chengcheng Zhang

3PUBLICATIONS
31CO-AUTHORS
Tumour immunologyHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Mar 27, 2025
Eph Receptors Activate Myeloid Checkpoint Receptor LILRB5 to Support Tumor Development.

Yubo He, Chengcheng Zhang, Lingxiao Tan

|Dec 19, 2023
LILRB3 Supports Immunosuppressive Activity of Myeloid Cells and Tumor Development.

Ryan Huang, Xiaoye Liu, Jaehyup Kim

Pageof 1